Suresh Senan
#119,711
Most Influential Person Now
Researcher
Suresh Senan's AcademicInfluence.com Rankings
Suresh Senanengineering Degrees
Engineering
#3732
World Rank
#4848
Historical Rank
Electrical Engineering
#866
World Rank
#937
Historical Rank
Suresh Senancomputer-science Degrees
Computer Science
#4777
World Rank
#5042
Historical Rank
Computational Linguistics
#530
World Rank
#538
Historical Rank
Machine Learning
#1049
World Rank
#1065
Historical Rank
Artificial Intelligence
#1279
World Rank
#1303
Historical Rank
Download Badge
Engineering Computer Science
Suresh Senan's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Suresh Senan Influential?
(Suggest an Edit or Addition)Suresh Senan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (1839)
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. (2015) (1151)
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013) (997)
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial (2019) (969)
- Prophylactic cranial irradiation in extensive small-cell lung cancer. (2007) (759)
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017) (616)
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study (2011) (602)
- Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. (2008) (537)
- Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. (2013) (485)
- Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. (2010) (452)
- Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. (2009) (434)
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial (2020) (412)
- Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. (2012) (398)
- Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial (2015) (381)
- 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. (2014) (362)
- An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. (2014) (348)
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017) (336)
- Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. (2012) (327)
- PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. (2016) (317)
- Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. (2005) (316)
- Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. (2004) (306)
- Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. (2009) (301)
- European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. (2010) (301)
- Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. (2011) (293)
- Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study (2009) (274)
- Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. (2013) (260)
- The oligometastatic state—separating truth from wishful thinking (2014) (250)
- Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. (2004) (232)
- Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial. (2020) (232)
- Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. (2013) (230)
- Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. (2009) (228)
- Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer (2011) (219)
- Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning. (2001) (213)
- Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. (2012) (210)
- Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. (2005) (210)
- Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. (2010) (208)
- Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. (2017) (204)
- ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. (2017) (196)
- Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. (2012) (181)
- Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. (2009) (174)
- Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial (2012) (171)
- Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. (2011) (167)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) (165)
- Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. (2010) (165)
- Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. (2012) (157)
- Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. (1999) (157)
- Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). (2011) (153)
- Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. (2013) (152)
- Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer (2022) (150)
- Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer (2011) (149)
- Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report. (2019) (148)
- European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. (2017) (147)
- Outcomes of Hypofractionated High‐Dose Radiotherapy in Poor‐Risk Patients with “Ultracentral” Non–Small Cell Lung Cancer (2016) (144)
- Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. (2013) (142)
- New developments in arc radiation therapy: a review. (2010) (138)
- Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity. (2010) (137)
- Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans. (2003) (137)
- High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. (2013) (132)
- Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning. (2001) (130)
- Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery. (2011) (123)
- Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. (2011) (118)
- Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial (2019) (118)
- Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment. (2016) (115)
- A critical review of recent developments in radiotherapy for non-small cell lung cancer (2016) (114)
- Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. (2009) (113)
- Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. (2007) (109)
- Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. (2014) (106)
- Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients. (1999) (106)
- Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. (2002) (105)
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial. (2020) (105)
- Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients. (2011) (105)
- Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial (2018) (104)
- Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. (1997) (100)
- Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer (2012) (99)
- Design of clinical trials of radiation combined with antiangiogenic therapy. (2007) (98)
- Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study (2006) (95)
- Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer (2011) (92)
- A simplified CT-based definition of the lymph node levels in the node negative neck. (1999) (91)
- Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. (2015) (91)
- A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results. (2019) (91)
- Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? (2002) (88)
- Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. (2018) (87)
- Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. (2010) (87)
- Volumetric modulated arc radiotherapy for vestibular schwannomas. (2009) (86)
- Predictive factors in radiotherapy for non-small cell lung cancer: present status. (2001) (86)
- Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review. (2017) (84)
- MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis. (2018) (84)
- Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. (2011) (84)
- RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy. (2011) (84)
- Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors. (2012) (81)
- Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data. (2010) (81)
- Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? (2003) (81)
- Defining a standard set of patient-centred outcomes for lung cancer (2016) (78)
- Residual disease at the bronchial stump after curative resection for lung cancer. (2007) (76)
- Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? (2013) (74)
- Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool. (2010) (73)
- Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial. (2015) (73)
- 4D imaging for target definition in stereotactic radiotherapy for lung cancer (2006) (73)
- Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. (2006) (71)
- Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies. (2018) (71)
- Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies. (2011) (71)
- Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx. (1998) (70)
- Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer. (2009) (69)
- Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review (2020) (68)
- Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. (2008) (67)
- Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans. (2001) (66)
- Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. (2015) (65)
- Renal mobility during uncoached quiet respiration: an analysis of 4DCT scans. (2006) (64)
- A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer (2006) (64)
- Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. (2015) (63)
- Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. (2008) (62)
- Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study). (2011) (61)
- Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs. (2013) (60)
- Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy (2009) (60)
- Induction treatment before surgery for non-small cell lung cancer. (2003) (60)
- Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes (2013) (59)
- An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer. (1999) (59)
- Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer? (2007) (58)
- Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer. (2012) (57)
- Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer (2011) (56)
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. (2020) (56)
- Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review. (2016) (55)
- Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes. (2015) (55)
- Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy (2015) (54)
- Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. (2008) (53)
- When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis. (2014) (53)
- Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial. (2017) (53)
- Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) (52)
- Critical review of PET-CT for radiotherapy planning in lung cancer. (2005) (52)
- Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement. (2007) (52)
- Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis. (2016) (52)
- A new approach to quantifying lung damage after stereotactic body radiation therapy (2011) (52)
- Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases. (2018) (51)
- Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation. (1994) (50)
- Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors. (2019) (50)
- Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. (2020) (49)
- Stereotactic ablative radiotherapy: what's in a name? (2011) (49)
- Impact of the calculation resolution of AAA for small fields and RapidArc treatment plans. (2011) (49)
- Stage I Non-small Cell Lung Cancer (NSCLC) in Patients Aged 75 Years and Older: Does Age Determine Survival After Radical Treatment? (2010) (48)
- PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predom (2009) (48)
- Radiotherapy for lung cancer: clinical impact of recent technical advances. (2009) (47)
- Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery. (2013) (47)
- Impact of audio-coaching on the position of lung tumors. (2008) (44)
- Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. (2019) (44)
- Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis. (2011) (44)
- Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks. (1997) (44)
- Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe (2020) (44)
- Color intensity projections: a rapid approach for evaluating four-dimensional CT scans in treatment planning. (2006) (42)
- Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer. (2016) (42)
- Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. (2011) (42)
- Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy (2020) (41)
- The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms (2011) (41)
- An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilization. (2012) (40)
- What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? (2002) (40)
- Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. (2013) (40)
- Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques. (2012) (39)
- Scientific Advances in Thoracic Oncology 2016. (2017) (39)
- Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) - Extended Long-Term Outcomes. (2022) (39)
- Radiotherapy in small-cell lung cancer: lessons learned and future directions. (2011) (39)
- Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm (2017) (39)
- Volumetric Modulated Arc Therapy for Advanced Pancreatic Cancer (2010) (39)
- Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial (1997) (38)
- A four-dimensional CT-based evaluation of techniques for gastric irradiation. (2007) (38)
- Analysis of carina position as surrogate marker for delivering phase-gated radiotherapy. (2008) (37)
- Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. (2011) (37)
- Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging? (2007) (37)
- Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. (2018) (37)
- High-dose, conventionally fractionated thoracic reirradiation for lung tumors. (2014) (36)
- Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada. (2014) (36)
- Defining target volumes for non-small cell lung carcinoma. (2004) (36)
- Stereotactic radiotherapy for stage I lung cancer: current results and new developments. (2010) (36)
- A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study (2015) (35)
- Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography. (2012) (35)
- Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs (DRR). (2003) (34)
- Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors. (2008) (34)
- Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma (2007) (34)
- A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. (2011) (33)
- Evaluating mobility for radiotherapy planning of lung tumors: a comparison of virtual fluoroscopy and 4DCT. (2006) (33)
- Imaging texture analysis for automated prediction of lung cancer recurrence after stereotactic radiotherapy (2015) (33)
- Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer (2006) (32)
- Imaging for stereotactic spine radiotherapy: clinical considerations. (2011) (32)
- Markerless tracking of small lung tumors for stereotactic radiotherapy. (2015) (32)
- Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. (2016) (31)
- Radiotherapy for extensive stage small-cell lung cancer – Authors' reply (2015) (31)
- LBA49 Durvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trial (2020) (31)
- Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment. (2015) (31)
- Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study. (2019) (31)
- Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC) (2019) (31)
- Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial. (2019) (31)
- Restaging of Mediastinal Nodes with Transbronchial Needle Aspiration after Induction Chemoradiation for Locally Advanced Non-small Cell Lung Cancer (2007) (30)
- Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy (2018) (30)
- Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care? (2012) (30)
- Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study. (2020) (30)
- Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. (2013) (29)
- An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer. (2001) (29)
- Dosimetric impact of intrafraction motion during RapidArc stereotactic vertebral radiation therapy using flattened and flattening filter-free beams. (2013) (29)
- Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial. (2009) (29)
- Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques. (2013) (28)
- Comments on ‘Single-Arc IMRT?’ (2009) (28)
- Tumor Cavitation in Patients With Stage III Non–Small-Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy: Incidence and Outcomes (2012) (27)
- Fatal interstitial lung disease after erlotinib for non-small cell lung cancer. (2008) (27)
- Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model. (2015) (27)
- Second primary lung cancers following a diagnosis of primary head and neck cancer. (2015) (26)
- Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy. (2019) (26)
- New techniques for assessing response after hypofractionated radiotherapy for lung cancer. (2014) (26)
- A Primer on Interstitial Lung Disease and Thoracic Radiation. (2020) (25)
- Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. (2018) (25)
- Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors. (2017) (25)
- Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy (2011) (24)
- Population‐Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013 (2016) (24)
- Surgery versus stereotactic radiotherapy for patients with early‐stage non–small cell lung cancer (2013) (24)
- Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review (2021) (23)
- Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. (2019) (23)
- Systematic review of brain metastases prognostic indices. (2013) (23)
- Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993) (2007) (23)
- 2158 An analysis of anatomic landmark mobility and setup errors in radiotherapy for lung cancer (1997) (22)
- Indications and limitations of radiotherapy in malignant pleural mesothelioma (2003) (22)
- Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial. (2018) (22)
- Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocol. (2013) (22)
- Stage I nonsmall cell lung cancer in patients aged ≥75 years (2010) (21)
- Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC. (2005) (21)
- Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis. (2014) (21)
- A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993–22993) (2007) (21)
- Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. (2019) (21)
- Comparing rigid and deformable dose registration for high dose thoracic re-irradiation. (2013) (21)
- Verifying 4D gated radiotherapy using time-integrated electronic portal imaging: a phantom and clinical study (2007) (21)
- A CT-assisted method of dosimetry in brachytherapy of lung cancer. Rotterdam Oncological Thoracic Study Group. (2000) (21)
- Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non–Small Cell Lung Cancer (2018) (20)
- Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. (2018) (20)
- Stereotactic radiotherapy for centrally located early-stage lung tumors. (2007) (20)
- Time for reappraisal of extracranial treatment options? (2011) (19)
- Digital tomosynthesis (DTS) for verification of target position in early stage lung cancer patients. (2013) (18)
- Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)? (2002) (18)
- Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early‐Stage Lung Tumors: A Pictorial Essay (2018) (18)
- End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom. (2019) (18)
- Beam intensity modulation for penumbra enhancement in the treatment of lung cancer. (1999) (18)
- Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). (2020) (18)
- Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small‐cell Lung Cancer (2017) (18)
- Treatment recommendations by clinicians in stage I non-small cell lung cancer: A study of factors that influence the likelihood of accounting for the patient's preference. (2016) (18)
- The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer (2020) (17)
- Malignant pineal teratomas: a report on three patients and the case for craniospinal irradiation following chemotherapy. (1991) (17)
- Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer (2016) (17)
- Brachytherapy for recurrent head and neck cancer. (1999) (17)
- Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer. (2013) (17)
- Plasma cell granuloma of the middle ear and mastoid. Case report. (1993) (16)
- Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgery. (2013) (16)
- Improving radiotherapy planning for large volume lung cancer: A dosimetric comparison between hybrid-IMRT and RapidArc (2015) (16)
- Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach (2020) (16)
- Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies. (2010) (16)
- Is SABR cost-effective in oligometastatic cancer? An economic analysis of the SABR-COMET randomized trial. (2020) (16)
- A Brief Report on Outcomes of Stereotactic Ablative Radiotherapy for a Second Primary Lung Cancer: Evidence in Support of Routine CT Surveillance (2014) (16)
- Volumetric Modulated Arc Therapy (RapidArc) for Rapid, Non-invasive Stereotactic Radiosurgery of Multiple Brain Metastases (2008) (15)
- An evaluation of two internal surrogates for determining the three-dimensional position of peripheral lung tumors. (2009) (15)
- Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial (2020) (15)
- Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsquamous non-small cell lung cancer (nsNSCLC). (2015) (15)
- High-dose conventional thoracic re-irradiation for lung cancer: updated results. (2015) (14)
- Curative radiotherapy for a second primary lung cancer arising after pneumonectomy -- techniques and results. (2002) (14)
- Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications? (2016) (14)
- A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer. (2004) (14)
- A statistical comparison of prognostic index systems for brain metastases after stereotactic radiosurgery or fractionated stereotactic radiation therapy. (2013) (14)
- A Brief Report of 10-Year Trends in the Use of Stereotactic Lung Radiotherapy at a Dutch Academic Medical Center (2014) (14)
- Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. (2014) (14)
- Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors (2014) (13)
- Nasal peripheral T-cell lymphoma: a 20-year review of cases treated in Scotland. (1992) (13)
- Communicating cancer treatment information using the Web: utilizing the patient’s perspective in website development (2014) (13)
- Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010 (2014) (13)
- Lung cancer: intensity-modulated radiation therapy, four-dimensional imaging and mobility management. (2007) (13)
- The role of radiotherapy in non-small-cell lung cancer. (2005) (13)
- A novel simple approach for incorporation of respiratory motion in stereotactic treatments of lung tumors. (2010) (12)
- Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer (2007) (12)
- Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations. (2014) (12)
- Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function. (2014) (12)
- Identifying barriers to accrual in radiation oncology randomized trials. (2017) (12)
- Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply. (2015) (12)
- Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology (2016) (12)
- Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches. (2018) (12)
- Surgery for early-stage lung cancer: post-operative 30-day versus 90-day mortality and patient-centred care. (2014) (11)
- A Population‐Based Study of Outcomes in Surgically Resected T3N0 Non–Small Cell Lung Cancer in The Netherlands, Defined Using TNM‐7 and TNM‐8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm (2019) (11)
- Considerations for post-operative radiotherapy to the hemithorax following extrapleural pneumonectomy in malignant pleural mesothelioma. (2004) (11)
- An Individual Patient Data Meta-Analysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small Cell Lung Cancer (2014) (11)
- The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer? (2017) (11)
- Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study. (2020) (11)
- Systematic review of fractionated brain metastases radiotherapy (2014) (11)
- Withholding Stereotactic Radiotherapy in Elderly Patients with Stage I Non-small Cell Lung Cancer and Co-existing COPD is not Justified: Outcomes of a Markov Model Analysis (2011) (11)
- Radiographic Changes After Lung Stereotactic Ablative Radiotherapy (SABR) -- Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature. (2013) (10)
- A Phase II Study of Induction Therapy with Carboplatin and Gemcitabine among Patients with Locally Advanced Non-small Cell Lung Cancer (2006) (10)
- Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning. (2011) (10)
- Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm. (2019) (10)
- Use of megavoltage cine-images for studying intra-thoracic motion during radiotherapy for locally advanced lung cancer. (2011) (10)
- Mucosal dose prescription in endobronchial brachytherapy: a study based on CT-dosimetry. (2000) (10)
- Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer. (2017) (10)
- Involved-node radiotherapy to the mediastinum. (2007) (10)
- Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy (2017) (10)
- The Impact of Staging by Positron‐Emission Tomography on Overall Survival and Progression‐Free Survival in Patients With Locally Advanced NSCLC (2018) (9)
- Texture analysis of automatic graph cuts segmentations for detection of lung cancer recurrence after stereotactic radiotherapy (2015) (9)
- Automated Texture Analysis for Prediction of Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer (2015) (9)
- Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences after sequential chemotherapy and “involved-field” radiotherapy to 70 gy (2001) (9)
- 1009 : Quality of Life After Stereotactic Radiotherapy for Medically Inoperable Stage I Lung Cancer (2006) (9)
- Treatment-Related Toxicity in Patients with Early Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review. (2017) (9)
- 2nd ESMO Consensus Conference on Lung Cancer : non-small-cell lung cancer first-line/second and further lines in advanced disease (2014) (9)
- Flattening Filter-free Beams for SBRT: Advantages and Risks (2012) (8)
- MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts (2018) (8)
- Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease (2020) (8)
- ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer. (2019) (8)
- Inferring positions of tumor and nodes in Stage III lung cancer from multiple anatomical surrogates using four-dimensional computed tomography. (2010) (8)
- Cigarette smoking is a risk factor for bleomycin-induced pulmonary toxicity. (1992) (8)
- Health-related quality of life (HRQOL) after stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC). (2010) (8)
- Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer. (2009) (8)
- Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry. (2017) (8)
- Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017 (2018) (8)
- Randomized trial of standard dose to a higher dose prophylactic cranial irradiation (PCI) in limited-stage small cell cancer (SCLC) complete responders (CR): Primary endpoint analysis (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212) (2008) (8)
- Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC (2020) (8)
- Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study. (2010) (8)
- Pulmonary atelectasis after stereotactic ablative radiotherapy for a central lung tumor. (2013) (8)
- Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling. (2018) (7)
- Stereotactic Body Radiotherapy: Do Central Lung Tumors Still Represent a ‘No-Fly Zone’? (2012) (7)
- Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial (2022) (7)
- Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies (2017) (7)
- Consensus Conference on Lung Cancer : early-stage non-small-cell lung cancer consensus on diagnosis , treatment and follow-up (2014) (7)
- Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449) (2017) (7)
- Bowel-sparing intensity-modulated radiotherapy (IMRT) for palliation of large-volume pelvic bone metastases: Rationale, technique and clinical implementation (2013) (7)
- Early prediction of lung cancer recurrence after stereotactic radiotherapy using second order texture statistics (2014) (7)
- The diagnosis and treatment of nasal lymphoma, an important cause of upper respiratory tract destruction. (1992) (7)
- Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al. (2009) (7)
- Palliation of malignant phaeochromocytoma with combination chemotherapy. (1992) (7)
- Stages I-II non-small cell lung cancer treated using either lobectomy by video-assisted thoracoscopic surgery (VATS) or stereotactic ablative radiotherapy (SABR): Outcomes of a propensity score-matched analysis. (2012) (7)
- Age-related treatment patterns for stage I NSCLC in three European countries. (2021) (7)
- Color Intensity Projections: A Simple Way to Display Changes in Astronomical Images (2007) (7)
- Hypofractionated Stereotactic Radiation Therapy for Large and Central Lung Tumors (2012) (6)
- The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window. (2021) (6)
- Radiation oncology: overview and recent advances. (2010) (6)
- The MARS feasibility trial : Conclusions not supported by data - Authors' reply (2011) (6)
- Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy. (2015) (6)
- Time trends in target volumes during stereotactic radiotherapy for stage I non-small cell lung cancer (NSCLC) (2004) (6)
- Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer (2011) (6)
- The Impact of Introducing Stereotactic Body Radiotherapy in Elderly Patients with Stage I NSCLC: A Population-Based Time-Trend Analysis (2010) (6)
- Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer. (2017) (6)
- Developments in radiation techniques for thoracic malignancies (2021) (6)
- Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer. (2020) (6)
- CT image feature analysis in distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a preliminary study (2013) (6)
- Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. (2007) (6)
- Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands. (2018) (6)
- Novel tools in radiotherapy. (2008) (5)
- RapidArc vs. IMRT Planning: A Comparative Study with Dosimetric Validation for Head and Neck, Glioma and Pancreas Cancer (2008) (5)
- Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors (2014) (5)
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Randomized Trial (2020) (5)
- Analysis of components of variance determining probability of setup errors in CBCT‐guided stereotactic radiotherapy of lung tumors (2017) (5)
- An analysis of planned versus delivered airway doses during stereotactic lung radiotherapy for central tumors (2016) (5)
- Patient reported outcomes after the treatment of early stage non-small cell lung cancer by stereotactic body radiotherapy compared to surgery. (2018) (5)
- The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma. (2021) (5)
- Feasibility of using anatomical surrogates for predicting the position of lung tumours. (2012) (5)
- OC-0425 Clinical experience with stereotactic MR- guided adaptive radiation therapy for pancreatic tumors (2017) (5)
- 2206 Variability in contouring target volumes for lung cancer - evaluation of a treatment planning protocol for 3-D conformal radiotherapy (1999) (5)
- Conventional IMRT versus Volumetric Modulated Arc Therapy (RapidArc) for Pancreatic Cancer (2009) (4)
- Developments in early-stage NSCLC: advances in radiotherapy. (2012) (4)
- Curative Radiotherapy for Non-small Cell Lung Cancer: Practice Changing and Changing Practice? (2019) (4)
- TH‐C‐350‐03: A Dosimetric Validation of RapidArc Treatment Plans for 5 Treatment Sites (2008) (4)
- B5-04: Clinical results and toxicity after 4-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer (NSCLC) (2007) (4)
- Radiological and Clinical Pneumonitis After Stereotactic Lung Radiotherapy: A Matched Comparison of 3D-Conformal and Volumetric Modulated Arc Therapy Techniques (2010) (4)
- Predicting Symptomatic Radiation Pneumonitis After Concurrent Chemoradiation Therapy for Non-small Cell Lung Cancer: Results of an International Individual Patient Data Meta-analysis (2012) (4)
- International Multicenter Randomized Study on Thoracic Radiation Therapy (RT) in Extensive Stage Small Cell Lung Cancer (ES-SCLC): Patterns of Disease Recurrence (2014) (4)
- Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases. (2020) (4)
- 124: Detection of Local Cancer Recurrence after Stereotactic Ablative Radiotherapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment (2016) (4)
- The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis (2021) (4)
- Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Tumors (2017) (4)
- Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Prostate Cancer (2017) (4)
- Same-day consultation, simulation and lung SABR delivery on an MR-linac (2022) (4)
- [Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. (2008) (4)
- Treatment of malignant intracranial germ cell tumours. (1992) (4)
- SP-0494: Using a MRI-guided radiation therapy system for prostate cancer patients (2017) (4)
- Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery. (2011) (4)
- Advantages of Respiration-Gated Radiotherapy for Stage III Lung Cancer (2005) (4)
- Diagnostic challenges in survivors of early stage lung cancer. (2015) (4)
- The need for randomized trials in mesothelioma: let's walk the talk. (2011) (4)
- Current Status of Four-dimensional Computed Tomography for High-precision Radiotherapy (2006) (4)
- Impact of Daily Plan Adaptation on Organ-At-Risk Normal Tissue Complication Probability for Adrenal Lesions undergoing Stereotactic Ablative Radiation Therapy. (2021) (4)
- Organization--size and intensity (1978) (4)
- Corrigendum to “Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review” [Radiother Oncol 106 (2013) 276–282] (2013) (4)
- The use of CT-simulation and digitally reconstructed radiographs (DRR's) in setup verification allows for smaller planning target volumes in lung cancer (2000) (4)
- Randomized trial on thoracic radiotherapy (TRT) in extensive-stage small cell lung cancer. (2014) (4)
- Staging nodal disease in non-small cell lung cancer: implications for radiation therapy. (2007) (4)
- Surveillance with computed tomography after curative treatment of early-stage lung cancer. (2013) (4)
- Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiation for Stage III Non-Small-Cell Lung Cancer: Is There an Impact on Radiation Pneumonitis Rates? (2015) (4)
- Evaluation of a Software Tool for Verifying Tumor Motion and Breathing Patterns in Patients undergoing Stereotactic Radiotherapy (SRT) (2009) (4)
- Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy (2016) (3)
- 23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial (2021) (3)
- Stereotactic body radiotherapy for central lung tumours. (2015) (3)
- Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer (2013) (3)
- Defining a Standard Set of Patient Centered Outcomes for Patients With Lung Cancer (2015) (3)
- Online Intrafraction Spine Motion Monitoring Using Digital Tomosynthesis: Preliminary Phantom Results (2011) (3)
- Outcomes research: Radiotherapy capacity in Europe—time to even things out? (2013) (3)
- Incorporating lung tumor mobility in radiotherapy planning. (2002) (3)
- Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period. (2022) (3)
- Quantitative assessment of target delineation variability for thymic cancers: agreement evaluation of a prospective segmentation challenge (2016) (3)
- A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC) (2007) (3)
- Neuro-cognitive follow-up among patients with limited small cell cancer (SCLC) treated with two different doses of prophylactic cranial irradiation (PCI) according to the intergroup phase III trial (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212) (2009) (3)
- The history of radiotherapy in The Netherlands. (1996) (3)
- Impact of Daily Adaptive Plans for Stereotactic MR-Guided Radiation Therapy (SMART) in Early Stage Lung Cancer (2017) (3)
- Digital Tomosynthesis Performance for Spine Tracking (2012) (3)
- Outcome After Stereotactic Radiotherapy in ‘High-Risk’ Patients With Stage I Non-small Cell Lung Cancer (NSCLC) (2007) (3)
- 950O Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer: The INCREASE trial (2022) (3)
- Results from the AAPM Task Group 324 respiratory motion management in radiation oncology survey (2022) (3)
- 37 – Stage I Nonsmall Cell Lung Cancer and Oligometastatic Disease (2018) (3)
- Treatment Utilization and Survival for Elderly Patients with Stage I Nsclc: A Population-Based Time-Trend Analysis (2010) (3)
- Stereotactic Body Radiotherapy (SBRT) Outcomes in Stage I Lung Cancer Patients with Severe Chronic Obstructive Pulmonary Disease (GOLD III-IV) (2010) (3)
- 1529 poster PATIENT STABILITY DURING STEREOTACTIC BODY RADIOTHERAPY (SBRT) DELIVERED WITHOUT EXTERNAL IMMOBILIZATION (2011) (3)
- OC-0490: A robust and fast planning approach for adaptive MR-guided treatment of pancreatic cancer (2017) (3)
- Evaluating Digital Tomosynthesis (DTS) for Image-guided Stereotactic Lung Radiation Therapy (2012) (3)
- Determining Planning Priorities for Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Disease: A Secondary Analysis of the [TRIAL NAME REDACTED FOR REVIEW] Randomized Trial. (2022) (3)
- Stereotactic lung radiotherapy: do we need fiducial markers? (2011) (3)
- Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung Cancer. (2022) (3)
- Non-coplanar volumetric modulated arc therapy for irradiation of paranasal sinus tumors: in response to Al-Mamgani et al., Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (c (2013) (3)
- FEASIBILITY PHASE OF THE MESOTHELIOMA AND RADICAL SURGERY (MARS) RANDOMISED CONTROLLED TRIAL COMPARING EXTRA-PLEURAL PNEUMONECTOMY (EPP) WITH NO EPP IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (2011) (3)
- Complication probability for radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT). (2013) (3)
- Treatment for high-risk patients with early-stage non-small-cell lung cancer. (2015) (3)
- 61OOUTCOME OF SURGICAL SALVAGE FOR LOCAL FAILURES FOLLOWING STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) (2015) (3)
- Points to consider regarding the SABR-COMET trial – Authors' reply (2020) (2)
- A Hybrid IMRT Technique for High Dose Radiotherapy in Large-Volume Stage III Lung Tumors: Planning Comparison with 3 Other Techniques (2010) (2)
- Treatment of Stage IIIA Non-Small-Cell Lung Cancer: Charting the Next Steps. (2016) (2)
- The Diagnosis of Tumors. (1946) (2)
- Poster Viewing AbstractIs Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis (2014) (2)
- Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer. (2021) (2)
- A Novel Approach for Highly Conformal Irradiation of Vestibular Schwannoma using a Single Volumetric Aperture Based Intensity Modulated Arc (2008) (2)
- Outcomes of stereotactic body radiotherapy (SBRT) in 175 patients with stage I NSCLC aged 75 years and older. (2009) (2)
- Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries. (2019) (2)
- Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment (2016) (2)
- A need to standardize post-operative radiotherapy (PORT) fields used for non-small cell lung cancer (NSCLC): analysis of an international dummy-run study: A1-02 (2007) (2)
- A 4D CT Analysis of Techniques for Gastric Irradiation (2005) (2)
- Optimal Imaging Follow-up Schedules after Stereotactic Ablative Radiotherapy for Early Non-Small-Cell Lung Cancer: Findings of an International Delphi Consensus Study (2017) (2)
- Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR): 197PD (2016) (2)
- Radiotherapy plan quality using a double focused, double stacked multi-leaf collimator (2018) (2)
- Conventional 3 D staging PET / CT in CT simulation for lung cancer : impact of rigid and deformable target volume alignments for radiotherapy treatment planning (2011) (2)
- MA13.10 Magnetic Resonance Imaging-Guided Delivery of Lung Stereotactic Radiotherapy Using Patient-Controlled Visual Guidance (2017) (2)
- Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? (2022) (2)
- D1-02: Initial results from an intergroup phase III trial evaluating two different doses of prophylactic cranial irradiation (PCI) in patients with limited small cell cancer (SCLC) in complete remission (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212) (2007) (2)
- Prediction of 3D Position of Lung Tumors from Carina and Diaphragm Positions (2008) (2)
- Supporting Patients with Cancer after Dobbs v. Jackson Women’s Health Organization (2022) (2)
- The interaction of cisplatin and radiotherapy. (1993) (2)
- Patterns of Disease Recurrence Following Either Stereotactic Ablative Radiation Therapy (SABR) or Lobectomy by Video-assisted Thoracoscopic Surgery (VATS) in Stage I-II Non-small Cell Lung Cancer: Outcomes of a Propensity Score-matched Analysis (2012) (2)
- 1. MR-guided adaptive stereotactic radiotherapy: A new paradigm in radiotherapy (2017) (2)
- Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high‐risk, early‐stage non‐small cell lung cancer (2016) (2)
- Multidisciplinary Team Management of Lung Cancer (2007) (2)
- Blinded assessment of radiological changes after stereotactic ablative radiotherapy (SABR) for early-stage lung cancer: Local recurrences versus fibrosis. (2013) (2)
- Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022. (2012) (2)
- SU-E-T-246: Preliminary Normal Tissue Complication Probability (NTCP) Analysis for Radiation Pneumonitis (RP) after Stereotactic Body Radiotherapy (SBRT). (2012) (2)
- [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]. (2008) (2)
- Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy for newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) in a phase III study (RATIONALE 001). (2019) (2)
- Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial. (2018) (2)
- Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet (2019) (2)
- Assessment of Response After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Can Advanced CT Image Feature Analysis Predict Recurrence? (2013) (2)
- Can the probability of radiation esophagitis be reduced without compromising lung tumor control: A radiobiological modeling study (2016) (2)
- In reply to Zagar and Marks. (2012) (2)
- Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply. (2016) (2)
- A zetterbergian analysis of homans' (1961) exchange theoretic formulation : toward explication and codification in the exchange perspective (1976) (2)
- Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-Analysis of Propensity Score-Adjusted Comparative Effectiveness Studies (2017) (1)
- OC-0072 Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for adrenal oligometastases (2019) (1)
- 3003 Facility case volume and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy (2015) (1)
- Density Changes on Computed Tomography after Stereotactic Lung Radiotherapy: An Analysis of the Relationship between Dose and Lung Injury in 50 Patients (2010) (1)
- 256 INVITED Intensity Modulated Radiotherapy: Fixed-Beam and Arc Delivery Techniques for Locally Advanced Disease (2011) (1)
- MA02.02 Toxicity of Lung SABR in Patients with Coexisting Interstitial Lung Disease (2019) (1)
- O-19 Literature-based recommendations for treatment planning and execution in high-precision radiotherapy for lung cancer (2003) (1)
- Finding the Goldilocks zone in neoadjuvant radioimmunotherapy (2021) (1)
- P-744 Dosimetric gains from respiration-gated radiotherapy for stage III lung cancer: An analysis of 4DCT data (2005) (1)
- Advances in radiation oncology: PL3-02 (2007) (1)
- Adaptive Strategies to Reduce Toxicity of Stereotactic Body Radiotherapy (SBRT) for Large Stage I Lung Tumors (2010) (1)
- Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC (2021) (1)
- Critical factors for patient management. (2003) (1)
- Verifying 4 D gated radiotherapy using time-integrated electronic portal imaging : a phantom and clinical study (2015) (1)
- Abstract159: Treatment Compliance and Early Toxicity of 3D Involved-Field Radiotherapy (RT) and Chemotherapy (CT) in a Randomized Study Comparing Induction CT Followed by Concurrent CT-RT With Concurrent CT-RT Followed by Consolidation CT, in Non-Small-Cell Lung Cancer (NSCLC) (2006) (1)
- Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands. (2016) (1)
- Correlation, Causation and Confounding-What Is the True Risk of Lung Cancer following Breast Cancer Radiotherapy? (2017) (1)
- Lack of consensus on post-operative radiotherapy (PORT) fields used in non-small cell lung cancer (NSCLC) (2007) (1)
- Parenchymal lung changes on computed tomography after stereotactic radiotherapy using high dose rate flattening filter free beams. (2015) (1)
- Whole brain radiotherapy with concurrent erlotinib for brain metastases from non-small cell lung cancer: A phase I study (2008) (1)
- Improvements in Survival of Elderly Patients with Stage I NSCLC in the Netherlands between 2003-2009 (2011) (1)
- Target Volumes in Non-Small Cell Lung Cancer (2005) (1)
- Regarding scoring of radiation pneumonitis. (2000) (1)
- Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139. (2015) (1)
- [Guideline 'Radiotherapy in non-small-cell lung carcinoma']. (1998) (1)
- Dosimetry, Image Guidance, and Clinical Outcome of Sub-Centimeter Lung Tumors After Stereotactic Ablative Radiation Therapy (2014) (1)
- A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors: Results from the Dutch Lung Cancer Audit for Surgery (DLCA-S). (2021) (1)
- Evaluation of a workflow for cone‐beam CT‐guided online adaptive palliative radiotherapy planned using diagnostic CT scans (2022) (1)
- Conditional Survival Probabilities Following Stereotactic Body Radiation Therapy for Early-Stage Non-small Cell Lung Cancer (2017) (1)
- Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer (2019) (1)
- Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial (2012) (1)
- Computed tomography surveillance of patients with resected lung cancer: Recurrence or second primary lung cancer? (2014) (1)
- 48O TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MLPC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) (2013) (1)
- Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation. (2020) (1)
- P3-177: Essential role for intensity-modulated radiotherapy (IMRT) in post-pneumonectomy mediastinal radiotherapy for stage III-N2 non-small cell lung cancer (2007) (1)
- Development and validation of a sensitive solid-phase-extraction and high-performance liquid chromatography assay for the bioreductive agent tirapazamine and its major metabolites in mouse and human plasma for pharmacokinetically guided dose escalation (1995) (1)
- Evaluation of a care path for patients with lung tumors and co-existing interstitial lung disease. (2019) (1)
- Is radical chemo-radiotherapy appropriate in patients with stage IV non-small-cell lung cancer due to cervical lymph node metastases? (2016) (1)
- The radiobiological basis of concomitant cisplatin and radiotherapy. (1993) (1)
- Inferring Positions of Tumor and Nodes in Stage III Lung Cancer from Multiple Anatomical Surrogates Using 4D CT (2010) (1)
- The elusive pursuit of progress in limited stage small-cell lung cancer. (2021) (1)
- Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis of >1000 Patients (2013) (1)
- Testing the Effects of Modality and Narration Style on Patients’ Information Use in a Lung Cancer Treatment Decision Aid (2020) (1)
- Oral Abstract PresentationAn Individual Patient Data Meta-Analysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small Cell Lung Cancer: Metastatic Non-Small Cell Lung Cancer (2014) (1)
- SBRT for pancreatic cancer: In regard of Bohoudi et al. (2018) (1)
- CT-guided pulmonary radiofrequency ablation. (2008) (1)
- VOLUMETRIC MODULATED ARC RADIOTHERAPY FOR RAPID DELIVERY OF STEREOTACTIC RADIOTHERAPY TO VERTEBRAL METASTASES (2009) (1)
- Beam intensity modulation (BIM) for penumbra enhancement in the treatment of non-small cell lung cancer (1998) (1)
- Predictors of Chest Wall Toxicity Following Risk-adapted Stereotactic Radiotherapy in 500 Patients Treated for Early Stage Lung Cancer (2011) (1)
- The Impact of Audio-Coaching on Tumor Position in 4DCT Scans (2007) (1)
- Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study. (2023) (1)
- Renal Mobility during Quiet Uncoached Respiration: An Analysis of 4DCT Scans (2005) (1)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (1)
- Nasopharyngeal and nasal malignant lymphoma [5] (1993) (1)
- Overcoming tumour radiation resistance resulting from acute hypoxia. (1992) (1)
- 8: Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-Comet Randomized Trial (2020) (1)
- Nasopharyngeal and nasal malignant lymphoma. (1993) (1)
- Radical-Intent Treatment of Lung Cancer after Prior Thoracic Radiotherapy. (2017) (1)
- Verification of Intrafraction Motion using Cine MV and Color Intensity Projections (2008) (1)
- Failure of palliative radiotherapy in high-grade angiosarcoma of bone. (1992) (1)
- Radiomics versus physician assessment for the early prediction of local cancer recurrence after stereotactic radiotherapy for lung cancer (2016) (1)
- Predicting Survival following Stereotactic Ablative Radiotherapy in Early-Stage Lung Cancer: A Recursive Partitioning Analysis to Define Risk Groups (2014) (1)
- Dosimetric Validation of RapidArc for Stereotactic Radiotherapy for Peripheral Lung Tumors (2009) (1)
- ROLE OF TORCH INFECTION, OXIDATIVE STRESS AND SOMATIC DNA DAMAGE IN HIGH-RISK PREGNANT WOMEN LEADING TO CONGENITAL ANOMALIES (2020) (1)
- CYTOGENETIC AND IMMUNOLOGIC STUDIES ON COUPLE EXPERIENCING BAD OBSTETRIC HISTORY (2016) (1)
- Radiotherapy for Locally Advanced Lung Cancer: IIIA/B (2008) (0)
- Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) in Stage I NSCLC (2017) (0)
- Defining Target Volumes for Radiotherapy of Peripheral Lung Tumors: A Comparison of F-18-FDG-positron Emission Tomography and 4-dimensional CT Scans (2010) (0)
- Abortion and The Hippocratic Oath: Historical Aspects. (2022) (0)
- 50O PREDICTORS FOR RADIATION PNEUMONITIS AFTER SABR FOR HIGH-RISK LUNG TUMORS (2013) (0)
- EORTC recommendations radiotherapy lung cancer 2017 1 European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer (2017) (0)
- NTCP modelling of pulmonary toxicity after stereotactic radiotherapy for central lung tumors (2018) (0)
- General and Theoretical: Six Essays in Comparative Sociology. Andre Beteille: Rational Choice and Social Exchange: A Critique of Exchange Theory. Anthony Heath (1977) (0)
- MA06.06 Treatment Recommendations for Stage III NSCLC by 3 Dutch Multidisciplinary Tumor Boards Prior To, and Following the PACIFIC Trial (2021) (0)
- Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) in Stage I NSCLC (2017) (0)
- Four-dimensional Radiation Therapy for Non-Small Cell Lung Cancer: A Clinical Perspective (2011) (0)
- Modeling of Radiographic Changes in Normal Lung Tissue in Patients Treated With Conventional and Hypofractionated Radiation Therapy (2012) (0)
- Potential Useful Application of Indigenous Extracts in Ornamental Fishes Affecting Aeromonas hydrophila Infection (2018) (0)
- RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC). (2019) (0)
- Imaging for high-precision thoracic radiotherapy. (2012) (0)
- P-187 A multicenter phase II study of induction chemotherapy withgemcitabine and carboplatin in patients (pts) with locally advanced non-small cell lung cancer (NSCLC) (2005) (0)
- CT-assisted brachytherapy (BT) planning for nasopharyngeal cancer (NPC) (1999) (0)
- Exploring controversies in lung cancer using structured pro-con debates. (2015) (0)
- Prevention and therapy of tumors (2002) (0)
- 68INSTEREOTACTIC ABLATIVE RADIOTHERAPY IN EARLY STAGE NSCLC. (2014) (0)
- Cost-Effectiveness of SABR in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-COMET Trial. (2021) (0)
- A critical review of recent developments in radiotherapy for non-small cell lung cancer (2016) (0)
- High-dose radiotherapy for ultracentral lung tumors in poor risk patients (2016) (0)
- SP-0366: Faster treatments, smaller margins? (2015) (0)
- SABR Given Thoughtfully. (2017) (0)
- Evidence of Teratogenicity and DNA Damage among Women with Second Trimester Abortions (2016) (0)
- High-dose radiotherapy for ultracentral lung tumors in poor risk patients (2016) (0)
- SBRT using MR-guided, video-assisted gated treatment delivery during patient breath holds (2018) (0)
- TARGET VOLUME DELINEATION FOR LUNG CANCER USING EITHER MAXIMAL INTENSITY PROJECTIONS OR DEFORMABLE REGISTRATION (2009) (0)
- OC-0468: Delivery of single-fraction lung SABR using MR-guidance (2020) (0)
- Target volume definition in non-small cell lung cancer using 3-dimensional image registration of pre- and post-chemotherapy CT scans (2001) (0)
- Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review (2020) (0)
- Primary intracranial germ cell tumours (GCT) fail to highlight important aspects of the current management of this condition. (1992) (0)
- PV-0238: Use of Stereotactic Ablative Radiotherapy in Non-Small Cell Lung Cancer Measuring 5 cm or More (2017) (0)
- 150Local control in cancer of the nasopharynx — Evidence for dose-response (1996) (0)
- RapidArc for Hippocampus-avoiding Prophylactic Cranial Irradiation (PCI) (2009) (0)
- PD-0743 Treatment patterns for adrenal metastases in the era of MR-guided stereotactic ablative radiotherapy (2021) (0)
- SBRT for early NSCLC: Markov model insight for optimal patient selection. (2011) (0)
- 897 poster SBRT FOR MEDICALLY OPERABLE AND INOPERABLE EARLY NSCLC: MARKOV INSIGHT FOR OPTIMAL PATIENT SELECTION (2011) (0)
- Target Volume Delineation in Stage I Lung Cancer: A Comparison of Maximal Intensity Projections (MIP) versus use of Deformable Registration (2009) (0)
- Verifying Reproducibility of Internal Anatomy During Respiration Gated Radiotherapy (RGRT) (2007) (0)
- The Impact of Thoracic Radiation Therapy on Survival in Extensive-Stage Small Cell Lung Cancer: A Meta-Analysis (2015) (0)
- ERRATUM: Correction for Incorrect Citation of Reference and Wording in a Table. (2011) (0)
- PH-0721: Predicting overall survival in central NSCLC treated with SBRT: nomogram development and validation (2020) (0)
- Identifying Barriers to Accrual in Radiation Oncology Randomized Trials: Insights From a Trial of Stereotactic Radiation for Oligometastatic Disease (2017) (0)
- Review of The mind stealers: Psychosurgery and mind control and Mind control. (1979) (0)
- A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC): P2-197 (2007) (0)
- A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study (2015) (0)
- Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer : Results From the ROSEL Randomized Controlled Trial and a Systematic Review (2016) (0)
- Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer (2016) (0)
- PO-1877: Survival and dosimetric parameters in stage III NSCLC patients undergoing radical chemoradiotherapy (2020) (0)
- OC-0068 MR-guided adaptive radiotherapy for intra-abdominal lymphoma (2019) (0)
- OA 16.01 Stereotactic Ablative Radiotherapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score-Adjusted Studies (2017) (0)
- Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial (2019) (0)
- 4-Dimensional Imaging for Radiation Oncology: A Clinical Perspective (2013) (0)
- 91 Quality of Life Outcomes After Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial (2019) (0)
- PD-0555: Dose-Dependent Splenic Volume Changes during Adrenal Adaptive Stereotactic Ablative Radiotherapy (2020) (0)
- 193: Dose-Dependent Splenic Volume Changes During Adrenal Adaptive Stereotactic Ablative Radiotherapy (2020) (0)
- The impact of staging by positron emission tomography (PET) on overall survival (OS) and progression-free survival (PFS) in the phase III PROCLAIM study (2016) (0)
- Erratum : Clinical Cancer Research (pp.31-38), The vertical axes in Figures 3 and 4, which show pharmacokinetics in individual patients, were incorrectly labeled 'plasma AUC (μg/ml x min).' (Clinical Cancer Research (January 1997) (31-38)) (1997) (0)
- Chapter 2 Radiation oncology: overview and recent advances (2010) (0)
- Letter in response to paper by Abratt et al., Cancer Chemother Pharmacol (1992) 30: 495 (1993) (0)
- Patterns of tumor recurrence following induction chemotherapy and involved-field″ radiotherapy (RT) to 70 Gy in stage 3 non-small cell lung cancer (NSCLC) (2000) (0)
- Anatomical and Biological Imaging (2005) (0)
- Quality of Life Outcomes after Stereotactic Ablative Radiotherapy (SABR) vs. Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial (2019) (0)
- Conventional 3-dimensional conformal radiotherapy (CRT) versus beam intensity modulated (IMRT) in lung cancer: An analysis in patients irradiated to 70 Gy radiotherapy (2000) (0)
- General and Theoretical: Power: The Inner Experience. David C. McClelland (1978) (0)
- Reduction in Normal Tissue Complication Probability by Stereotactic Magnetic Resonance-Guided Ablative Radiotherapy for Adrenal Lesions (2020) (0)
- Is Homans tautological (1979) (0)
- PO-0981 Role of on-table plan adaptation in MRguided ablative radiation therapy for central lung tumors (2019) (0)
- SP-0115: Combining research and clinical work - a radiation technologist's experience of multi-tasking (2013) (0)
- 1038: Reproducibility of Target Volumes Generated by Uncoached 4DCT Scans in Lung Cancer (2006) (0)
- Does Compromising Target Coverage Impact Overall Survival when Treating Oligometastatic Disease with Stereotactic Ablative Radiotherapy (SABR)? (2022) (0)
- SP-0367: Absorbed dose treatment planning in radionuclide therapy (2010) (0)
- An analysis of the mobility of lung tumors of the lower lobe using multiple standard and ‘slow’ CT scans (2002) (0)
- 96 : Modelling Esophageal Mobility Using 4DCT Data Acquired During Normal Respiration (2006) (0)
- WE-AB-202-02: Incorporating Regional Ventilation Function in Predicting Radiation Fibrosis After Concurrent Chemoradiotherapy for Lung Cancer. (2016) (0)
- Curative Radiotherapy in Patients Inoperable for Medical Reasons (2013) (0)
- (P36) Stereotactic MRI-Guided Adaptive Radiotherapy for Adrenal Metastases (2018) (0)
- In regard to Rosenman et al., high-dose conformal radiotherapy for treatment of stage III A/B non-small-cell lung cancer: technical issues and results of a phase I/II trial. IJROBP 2002;54:348-356. (2003) (0)
- Randomized trials comparing SABR and surgery for early stage NSCLC: Design and endpoints (2016) (0)
- Randomized trials comparing SABR and surgery for early stage NSCLC: Design and endpoints (2016) (0)
- Radiographic Changes After Lung Stereotactic Ablative Radiation Therapy (SABR) - Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature (2012) (0)
- An analysis of the mobility of mediastinal nodes using multiple CT scans (2001) (0)
- MS 11.04 Radiation Therapy for Superior Sulcus Tumor (2017) (0)
- Stereotactic radiotherapy for centrally located stage I lung cancer: results of a 'risk-adapted' 60 Gy scheme (2009) (0)
- PO-0691: SABR for central lung tumors: plan quality and long-term clinical outcomes (2016) (0)
- D7-01: 4-dimensional respiration-gated radiotherapy for concurrent chemo-radiotherapy in lung cancer (2007) (0)
- 2IN EARLY AND LOCALLY ADVANCED DISEASE (2011) (0)
- MO-SAM-BRB-04: Use of Volumetric Modulated Arc Therapy for Intra and Extra Cranial Stereotactic Radiosurgery (2010) (0)
- In Reply to Cobben and Jager. (2015) (0)
- THE SUITABILITY OF CYTOLOGY AND SMALL BIOPSY SPECIMENS FOR EGFR MUTATION TESTING IN METASTATIC LUNG CANCER (2016) (0)
- P2.14-019 Magnetic Resonance (MR)-Guided Adaptive Stereotactic Ablative Radiotherapy for Adrenal Metastases (2017) (0)
- Letter to the editor (1992) (0)
- PO-0928 DOSIMETRIC IMPACT OF INTRA-FRACTION SHIFTS DURING VERTEBRAL SBRT USING FLATTENED AND FLATTENING FILTER FREE BEAMS (2012) (0)
- 1526 poster FLATTENING FILTER FREE BEAMS FOR LUNG AND SPINE SBRT (2011) (0)
- 2809 Comparison of T2 and FLAIR Imaging for Target Delineation in High Grade Gliomas (2008) (0)
- 192: Magnetic Resonance-Guided Adaptive Radiotherapy Reduces The Normal Tissue Complication Probability of Adrenal Stereotactic Ablative Radiotherapy (2020) (0)
- Chapter 3 Stereotactic ablative radiotherapy for central lung tumors : plan quality and long-term clinical outcomes (2018) (0)
- 119TiP Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC: The DIRECT-trial (2021) (0)
- OC-0104 Stereotactic radiation for treatment of oligometastases (SABR-COMET) – Extended long-term outcomes (2022) (0)
- Dosimetric rationale for curative radiotherapy schemes in occult lung carcinoma (2000) (0)
- 238: Risks of SABR for Early-Stage Non-Small Cell Lung Cancer with Co-Existing Interstitial Lung Disease: A Systematic Review of Literature (2016) (0)
- Homans, reductionism, and sociology: A reappraisal (1980) (0)
- When is a Biopsy-Proven Diagnosis Necessary Before Stereotactic Ablative Radiation Therapy for Lung Cancer? A Decision Analysis (2014) (0)
- Defining target volumes for treatment of peripheral lung tumours with radiotherapy: A comparison of 18F-FDG-positron emission tomography and 4-dimensional CT scanning (2010) (0)
- Radiotherapy for locally advanced lung cancer: Stages iiia and iiib (2012) (0)
- SP-0678 SBRT for oligometastatic NSCLC (2019) (0)
- 9122 Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC) (2009) (0)
- Does Surgery Have a Role in the Era of High Dose Chemoradiotherapy for Locally Advanced NSCLC (2011) (0)
- 108: Early Clinical Effectiveness, Toxicity, and Quality of Life Outcomes of Magnetic Resonance Imaging-Guided Stereotactic Ablative Radiotherapy: A Systematic Review (2022) (0)
- Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors (2023) (0)
- The First Preparatory Schooling. (2021) (0)
- Accuracy of deformable image registration-based intra-fraction motion management in Magnetic Resonance-guided radiotherapy. (2023) (0)
- Estimating the Population Impact of Introducing Stereotactic Ablative Radiation Therapy for Stage I NSCLC in Canada (2014) (0)
- Fellowships Grants and Awards (2002) (0)
- Risks of Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer With Co-Existing Interstitial Lung Disease: A Systematic Review of Literature (2016) (0)
- Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline (2023) (0)
- Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac (2022) (0)
- Erratum: Radiological changes after stereotactic radiotherapy for stage I lung cancer (Journal of Thoracic Oncology (2011) 7 (1221-1228)) (2011) (0)
- Digital Tomosynthesis for Verifying Lung Tumor Position (2013) (0)
- Letter to the editor (2005) (0)
- Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial (2020) (0)
- 17 Optimized time course in fractionated intraoperative brachytherapy for cancer in the head and neck (1998) (0)
- Reflections on the 14th World Conference on Lung Cancer: A European Perspective. (2012) (0)
- INTERNAL SURROGATES FOR 3D LUNG TUMOR POSITION (2009) (0)
- 56O OUTCOMES OF CONCURRENT CHEMO-RADIOTHERAPY FOR LARGE-VOLUME STAGE III NSCLC (2013) (0)
- Histopathologic changes due to neo-adjuvant chemoradiotherapy in resected NSCLC (2009) (0)
- Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Adrenal Metastases (2017) (0)
- Analysis of Intra-fractional Variability of the Internal Target Volume during Stereotactic Radiotherapy in Peripheral Lung Tumors (2010) (0)
- SU-E-J-149: Establishing the Relationship Between Pre-Treatment Lung Ventilation, Dose, and Toxicity Outcome. (2014) (0)
- MS07.05 Stage I (Resectable) NSCLC: Radiation (2019) (0)
- O-140 Quality of life after 4D stereotactic radiotherapy for stage I non-small cell lung cancer (NSCLC) (2005) (0)
- Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases (2021) (0)
- Stereotactic Ablative Radiotherapy (SABR) For Pathologically Confirmed Stage I NSCLC (2011) (0)
- SABR for Central Lung Tumors: Comparison With RTOG 0813 Dosimetric Criteria and Long-term Survival (2015) (0)
- Stereotactic Radiotherapy: the New Standard? (2010) (0)
- O-295 Accounting for tumor mobility of peripheral lung tumors: A 3D analysis in 29 patients (2003) (0)
- Curative Stereotactic Radiotherapy for Stage I Lung Cancer Arising after Previous Pneumonectomy (2008) (0)
- Diagnose van tumoren (2002) (0)
- PD-0095: Dosimetric parameters predictive for radiation pneumonitis after SABR for high-risk lung tumors (2013) (0)
- Stereotactic radiotherapy early stage NSCLC with poor lung function (2009) (0)
- RapidArc Planning and Delivery as Standard for Patients with Advanced Head and Neck Cancer (HNC) Undergoing Chemo-radiotherapy (2009) (0)
- P1.17-26 Delivery of Stereotactic MR-Guided Adaptive Radiation Therapy for Peripheral Lung Tumors (2019) (0)
- 1020P Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients: The RECLAIM study (2022) (0)
- OC-0411 Geometric efficacy of breath-hold gated MRguided SABR for adrenal metastases (2019) (0)
- Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models (2017) (0)
- Optimum management of pineal germ cell tumours (1991) (0)
- 156: Quality of Life Following Stereotactic Ablative Radiotherapy for Early Stage Lung Cancer: Results from the Rosel Randomized Controlled Trial and a Systematic Review (2016) (0)
- 60OANALYSIS OF LOCAL RECURRENCES FOLLOWING STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): DATA FROM A LARGE INSTITUTIONAL DATABASE (2015) (0)
- In Reply to Dr. Bauman (2010) (0)
- 92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET (2019) (0)
- Geometric efficacy of breath-hold gated MR-guided SABR for adrenal metastases (2019) (0)
- Markerless Tracking of Lung Tumors on Continuous kV Images (2014) (0)
- SP-0008 STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS STANDARD IN EARLY-STAGE NSCLC (2012) (0)
- Use of Color Intensity Projections (CIP) for 4D Respiration-Gated Radiotherapy (RGRT) (2005) (0)
- 370 oral EVALUATION OF THE ANISOTROPIC ANALYTICAL ALGORITHM FOR SMALL FIELD DOSIMETRY AND ITS INFLUENCE IN RAPIDARC DELIVERY (2011) (0)
- OC-0161: patient tolerance of stereotactic MR-guided adaptive radiation therapy: an assessment using PRO’s (2017) (0)
- PD-0398 Accumulated dose comparison of stereotactic MRgRT and proton therapy for central lung tumors (2022) (0)
- Diagnosis and treatment of lymphomatoid granulomatosis. (1992) (0)
- PL3-02: Advances in radiation oncology (2007) (0)
- Impact of the calculation resolution of AAA for small fields and RapidArc treatment plans. (2011) (0)
- ES06.02 Radiation and IO for Operable Early Stage NSCLC (2021) (0)
- Rapid Delivery of Stereotactic Radiotherapy for Peripheral Lung Tumors using Volumetric Intensity Modulated Arcs (2009) (0)
- Stage I (Resectable) NSCLC: Radiation (2019) (0)
- Salvage Surgery for Local Failures after Stereotactic Ablative Radiotherapy for Lung Malignancies (2015) (0)
- D1-01: Prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer (ED-SCLC) after response to chemotherapy (EORTC 08993-22993): Quality of life (QoL) results. (2007) (0)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (0)
- Short‐course, high‐dose image‐guided radiotherapy in poor risk patients with very central non‐small cell lung cancer: 116PD (2016) (0)
- Outcomes of Stereotactic Ablative Radiation Therapy (SABR) for a Second Primary Lung Cancer (SPLC): Evidence in Support of Routine CT Surveillance (2014) (0)
- PD5-2-2: Impact of mediastinal nodal mobility on the accuracy of transbronchial needle aspiration (TBNA) without real-time imaging (2007) (0)
- SBRT for oligometastatic NSCLC (2019) (0)
- PO-0996: Early mortality in stage III NSCLC after radical non-surgical therapy following ESMO guidelines (2020) (0)
- symposium article Novel tools in radiotherapy (2008) (0)
- Malignant pleural mesothelioma (MM): Outcome following radiotherapy in 300 patients (1997) (0)
- MO-0311 One stop shop single fraction MR-guided stereotactic radiotherapy: Workflow and patient satisfaction (2022) (0)
- Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy. (2023) (0)
- PD-120 Determining lung tumor mobility for radiotherapy planning: Acomparison of fluoroscopy and 4D CT data (2005) (0)
- VMAT Planning for Large Volume Stage III Lung Cancer (2014) (0)
- EP-1957 An MR-based simulation procedure for individual assessment of tumor motion in MR-guided lung SABR (2019) (0)
- The curative treatment of stage I non-small cell lung cancer (2018) (0)
- STEREOTACTIC LUNG RADIOTHERAPY USING VOLUMETRIC MODULATED ARC THERAPY – A COMPARISON WITH CONVENTIONAL METHODS (2009) (0)
- PO-0875 DOSIMETRIC AUDIT IN A MULTICENTRE PHASE III TRIAL OF SURGERY VERSUS STEREOTACTIC RADIOTHERAPY FOR LUNG CANCER (2012) (0)
- SP-0761: Combining immunotherapy and thoracic radiotherapy in SCLC (2020) (0)
- 637Tumour hypoxia — A confouding factor in interstitial brachytherapy in an animal model (1996) (0)
- Use of Deformable Registration Tool for Verifying Tumor Position on Kilo-voltage Cone-beam CT Scans for Stage III Lung Cancer (2009) (0)
- Dose-Dependent Splenic Volume Changes during Adrenal Adaptive Stereotactic Ablative Radiotherapy (2020) (0)
- B-001PROPENSITY SCORE-MATCHED ANALYSIS OF STAGE I-II NON-SMALL CELL LUNG CANCER TREATED BY VIDEO-ASSISTED THORACOSCOPIC LOBECTOMY OR STEREOTACTIC ABLATIVE RADIOTHERAPY (2013) (0)
- E56. EORTC recommendations for treatment planning and execution in lung cancer: An update (2005) (0)
- OC-0777 MR-guided lung SBRT: consultation, simulation and treatment delivery in a single day (2022) (0)
- TH-A-WAB-11: A Novel Method to Determine Alpha/beta for Irradiated Normal Lung Tissue Using Computed Tomography Scans. (2013) (0)
- Letters to the editor (1992) (0)
- ED08.02 The Role of Radiotherapy in Early-Stage NSCLC (2017) (0)
- Point-Counterpoint: Dobbs Decision: Point: The State of Abortion Care in South Dakota: Past, Present, and Future. (2022) (0)
- Debate: For stereotactic radiotherapy in operable stage I tumors (2009) (0)
- Synchronous Brain Metastases from Non-Small Cell Lung Cancer: Time for Reappraisal of Extracranial Treatment Options? (2010) (0)
- 63PDCOMPARISON OF CLINICAL OUTCOME OF STAGE I NON-SMALL CELL LUNG CANCER TREATED SURGICALLY OR WITH STEREOTACTIC RADIOTHERAPY: RESULTS FROM PROPENSITY SCORE ANALYSIS (2015) (0)
- Impact of mediastinal nodal mobility on the accuracy of transbronchial needle aspiration (TBNA) without real-time imaging: PD5-2-2 (2007) (0)
- Feasibility of Salvage Resection Following Locoregional Failure after Chemoradiotherapy and Consolidation Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer (2023) (0)
- OC-0424 Target volume time trends during daily adaptive 5-fraction MR-guided radiotherapy (2022) (0)
- Safety and resource use in the PROCLAIM study comparing 2 regimens of concurrent chemoradiation followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer (NSCLC). (2016) (0)
- An evaluation of websites providing patient information on stereotactic body radiation therapy (SBRT) for stage I lung cancer in three Western European countries. (2012) (0)
- Reply to "Radiation pneumonitis and docetaxel". (2004) (0)
- 2724 : Verification of Average Tumor Position for Phase-Gated Lung Cancer Patients Using Integrated EPIDs (2006) (0)
- Cisplatin/Gemcitabine followed by Cisplatin/Etoposide and concurrent thoracic radiotherapy in patients with irresectable or medically inoperable non-small-cell lung cancer: P2-203 (2007) (0)
- Clinical Implementation of Single Visit Palliative Adaptive Radiotherapy without Prior CT Simulation (2022) (0)
- EARLY AND LOCALLY ADVANCED DISEASE (2011) (0)
- MO‐EE‐A3‐02: Inferring Nodal Volume and Primary Tumor Positions From Multiple Anatomical Surrogates Using 4D CT in Stage III Lung Cancer (2009) (0)
- Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable? (2013) (0)
- Radiotherapy quality assurance of concurrent chemoradiotherapy in PROCLAIM phase III trial (2017) (0)
- Preliminary Statistical Dose Tolerance Limits for Radiation Pneumonitis (RP) When Treating Large Primary Lung Cancers With Stereotactic Body Radiation Therapy (SBRT) (2012) (0)
- Treatment of peripheral lung tumors arising after a prior pneumonectomy. (2012) (0)
- Combined radiotherapy with conventional chemotherapy and molecular targeted agents (2011) (0)
- Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer >80 cm3: Correlation of Early Toxicity with Planning Parameters (2010) (0)
- 2460 : Use of Carina Position To Verify Gated RT Delivery: A 4D Analysis During Planning and Delivery (2006) (0)
- Using Deformable Dose Registration to Improve Planning for High-dose Thoracic Reirradiation (2012) (0)
- Comment on: High-dose conformal radiotherapy for treatment of stage III A/B non-small-cell lung cancer: Technical issues and results of a phase I/II trial. Authors' reply (2003) (0)
- Esophagus toxicity after stereotactic radiotherapy of central lung tumor: NTCP modelling (2018) (0)
- USE OF A STANDARD CONSTRAINT SET FOR PLANNING OF RAPIDARC IN ADVANCED HEAD AND NECK TUMOURS (2009) (0)
- Early detection of lung cancer recurrence after stereotactic ablative radiation therapy: radiomics system design (2018) (0)
- MA02.05 Patient Selection and Early Clinical Outcomes of MR-Guided SABR in 54 Lung Tumors (2019) (0)
- Assessment of variations in contouring volumes in lung cancer - Evaluation of a treatment planning protocol (1999) (0)
- Pulmonary Function Changes After Stereotactic Ablative Radiotherapy In 201 Patients With Stage I Non-small Cell Lung Cancer (2011) (0)
- Letter to the editor [4] (1993) (0)
- Radiation Therapy for Superior Sulcus Tumor (2017) (0)
- What causes early mortality in patients with large tumors receiving radical chemo-radiotherapy for non-small cell lung cancer? In response to Ball et al. (2013) (0)
- Quality Assurance of Stereotactic Radiotherapy Techniques for a Randomized Phase III Trial Comparing Surgery to Radiosurgery (ROSEL) for Stage Ia NSCLC (2009) (0)
- PO-0674: SABR for lung tumors of 5cm or more: can knowledge-based planning detect high-risk treatment plans? (2017) (0)
- P18.02 Factors Influencing Multi-Disciplinary Tumor Board Recommendations in Stage III Non-Small Cell Lung Cancer (2021) (0)
- 8505 RapidArc for locally advanced head and neck cancer – first clinical results (2009) (0)
- Contour Propagation on Thoracic 4-dimensional CT Scans in Locally-advanced Lung Cancer using Deformable Registration (2009) (0)
- When is a pathologic diagnosis preferred before stereotactic ablative radiotherapy for stage I lung cancer? A decision analysis. (2014) (0)
- Preventie en therapie van tumoren (2002) (0)
- PO-1002: Early outcomes of stereotactic MR-guided adaptive radiation therapy in 54 high-risk lung tumors (2020) (0)
- THE USE OF ORTHOGONAL KV IMAGE PAIRS OR CBCT FOR SETUP CORRECTION FOR STAGE III LUNG TUMORS (2009) (0)
- PD-099 Approaches for identifying patients suitable for respiration-gatedradiotherapy in stage I lung cancer (2005) (0)
- Differences still exist in the approach to the diagnosis and management of pineal lesions. (1993) (0)
- The authors reply [4] (2007) (0)
- P1.05-061 Increased Treatment-Related Toxicity in Patients with Early-Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: Topic: Miscellaneous (2017) (0)
- Patterns of Recurrence Following Stereotactic Ablative Body Radiation Therapy (SABR) for Stage I-II NSCLC: Initial Sites and Timing (2012) (0)
- MR-guided Stereotactic Body Radiation Therapy for Large Primary Kidney Tumors (2020) (0)
- Role of Daily Plan Adaption during Breath-Hold MR-Guided Stereotactic Ablative Radiotherapy for Adrenal Metastases (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Suresh Senan?
Suresh Senan is affiliated with the following schools:
